Literature DB >> 28914369

Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study.

Jesús K Yamamoto-Furusho1, Andrea Sarmiento-Aguilar2.   

Abstract

The most frequent extra-intestinal manifestation in ulcerative colitis (UC) around the world is joint involvement. There are no previous data in Latin America that is about this aspect of disease; hence, the aim of this study was to determine the frequency and factors associated to joint involvement in Mexican patients with UC. A total of 295 patients with histological diagnosis of UC were studied, divided into two groups: (1) 154 cases with at least one joint affection (arthralgia, peripheral, or axial arthropathy (sacroilitis (SI) or ankylosing spondylitis (AS))) and (2) 141 controls that had never presented any joint involvement during the clinical course of UC. Demographic, clinical, and laboratory variables were collected from the clinical records, at the time of presentation of the joint involvement for the cases and with the last information available for controls. A total of 52.2% of the patients had joint involvement, which was also the most frequent extra-intestinal manifestation (EIM). The frequency of peripheral arthralgia was 46.8% and of axial arthropathy was 5.4% (2.7% AS, 2.4% SI, and 0.3% both). The female gender (P = 0.01, OR = 3.061 95% CI: 1.311-7.15), elevated erythrocyte sedimentation rate (ESR) (P = 0.07, OR = 8.04 95% CI: 1.759-36.764), and moderate disease activity by Truelove and Witts criteria (P = 0.024, OR = 4.37 95% CI: 1.211-15.78) were factors associated at the time of presentation of the joint affection. Joint involvement is the most frequent EIM in Mexican patients with UC. The female gender, elevated ESR, and disease activity are factors associated with its presentation.

Entities:  

Keywords:  Ankylosing spondylitis; Arthralgia; Axial arthritis; Joint; Sacroiliitis; Ulcerative colitis

Mesh:

Year:  2017        PMID: 28914369     DOI: 10.1007/s10067-017-3834-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  31 in total

1.  Peripheral arthritis in the course of inflammatory bowel diseases.

Authors:  Ilhami Yüksel; Hilmi Ataseven; Omer Başar; Seyfettin Köklü; Ibrahim Ertuğrul; Aysel Ulker; Ulkü Dağlı; Nurgül Saşmaz
Journal:  Dig Dis Sci       Date:  2010-05-11       Impact factor: 3.199

2.  Ileal pouchitis and arthritis.

Authors:  Ghada Abi Karam; Hassane Awada; Fouad Nasr; Imad Uthman
Journal:  Semin Arthritis Rheum       Date:  2003-12       Impact factor: 5.532

Review 3.  Extraintestinal manifestations in inflammatory bowel disease.

Authors:  Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

4.  Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.

Authors:  Maddalena Zippi; Claudia Corrado; Roberta Pica; Eleonora Veronica Avallone; Claudio Cassieri; Daniela De Nitto; Paolo Paoluzi; Piero Vernia
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

5.  Arthritis related to ileal pouchitis following total proctocolectomy for ulcerative colitis.

Authors:  A Balbir-Gurman; D Schapira; M Nahir
Journal:  Semin Arthritis Rheum       Date:  2001-02       Impact factor: 5.532

Review 6.  Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease: an update.

Authors:  Vera Kandror Denmark; Lloyd Mayer
Journal:  Expert Rev Clin Immunol       Date:  2013-01       Impact factor: 4.473

Review 7.  Immunogenicity and autoimmunity during anti-TNF therapy.

Authors:  F Atzeni; R Talotta; F Salaffi; A Cassinotti; V Varisco; M Battellino; S Ardizzone; F Pace; P Sarzi-Puttini
Journal:  Autoimmun Rev       Date:  2012-11-30       Impact factor: 9.754

Review 8.  Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature.

Authors:  D K Christodoulou; K H Katsanos; M Kitsanou; C Stergiopoulou; J Hatzis; E V Tsianos
Journal:  Dig Liver Dis       Date:  2002-11       Impact factor: 4.088

9.  The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients.

Authors:  S Leclerc-Jacob; G Lux; A C Rat; V Laurent; A Blum; I Chary-Valckenaere; L Peyrin-Biroulet; D Loeuille
Journal:  Aliment Pharmacol Ther       Date:  2014-03-04       Impact factor: 8.171

Review 10.  Enteropathic arthritis.

Authors:  Wendy Holden; Tim Orchard; Paul Wordsworth
Journal:  Rheum Dis Clin North Am       Date:  2003-08       Impact factor: 2.670

View more
  3 in total

1.  Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials.

Authors:  Lucas Guillo; Ferdinando D'Amico; Mélanie Serrero; Karine Angioi; Damien Loeuille; Antonio Costanzo; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2020-08-10       Impact factor: 4.623

2.  A comparison of the efficacy and safety of complementary and alternative therapies for ulcerative colitis: A protocol for systematic review and meta-analysis.

Authors:  Meiqi Lu; Ting Zhang; Zhen Lu; Wei Wang; Ting Chen; Zhiqun Cao
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

3.  Gancao Xiexin decoction combined with mesalazine in the treatment of ulcerative colitis: A protocol for a systematic review and meta-analysis.

Authors:  Chun Zhong; Xiaoming Cheng; Bo Jia; PeiYu Xiong; Jinhua Lu; Peixu Zhang; Xinglong Liu; Yunhui Chen
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.